Southend Hospital champions described as “ahead of their time” at anticoagulation awards held in London
16 September 2015
A multidisciplinary healthcare team dedicated to managing blood clots have been praised for their work and described as ahead of their time by the judging panel of a national quality awards.
The Quality in Care Anticoagulation programme 2015 held a
recognition event at London's Royal College of General
Practitioners on 10 September 2015, and the South East Essex Atrial
Fibrillation (AF) group was highly commended for its good practice
with anticoagulation management, education and patient care.
Champions from Southend University Hospital's stroke,
cardiology, clinical pharmacy, haematology and anticoagulation
services form part of the South East Essex Atrial Fibrillation (AF)
group alongside commissioners, and colleagues from primary
Anticoagulation is a therapy field that involves the prevention
and treatment of blood clots. It covers a range of conditions,
including deep vein thrombosis (DVT), pulmonary embolism (PE),
atrial fibrillation (AF) and endocarditis.
Commenting on the group's success, the judging panel, said:
"This work is sustainable and has great patient feedback. The team
proved to be ahead of their time by being early adopters of a
community-based approach to patients. It manages to pull lots of
different strands together and really maximised the levels of
support that could be offered to patients.
Formed in 2010 the South East Essex Atrial Fibrillation (AF)
group's achievements include reviewing local arrangements for use
of antithrombotic therapies in atrial fibrillation. It has also
provided education explaining how the use of aspirin should be
avoided for stroke prevention. The group also delivered a novel
anticoagulants NOAC clinic, enabling patients to be actively
involved in decisions about their anticoagulant treatment
Gaining recognition through QiC Anticoagulation Programme means
an initiative has been highlighted by the NHS, patients and
industry as improving patient outcomes and standards of care in the
treatment and prevention of blood clots.
Sue Hardy, chief executive at Southend University Hospital NHS
Foundation Trust, said: "We are delighted that the hard work and
high quality care of the atrial fibrillation team has been
recognised in the national arena and that we are able to share the
good practice here to benefit patients elsewhere in the
PHOTO (left to right):
- Terry Dowling - Assistant Lead Pharmacist - Medicine &
Governance Specialist Support Pharmacist - Anti-Coagulation,
Haematology & Oncology
- Kay Abbott - Clinical Nurse Specialist - Arrhythmia.
- Dr Paul Guyler - lead stroke consultant, Southend University
- Biju Kuriakose - Castle Point & Rochford CCG Board Member
and Cardiovascular Lead
- Host Dr Mark Porter (back row)
- Ameta Patel (front) - Anticoagulation Specialist
- Brian Houston - Southend CCG Board Member and Cardiovascular